Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
W. L. Gore & Associates, Inc. (Gore) hat bekannt gegeben, dass es die EMBRACE-Studie initiiert, um reale Daten über die GORE® VIABAHN® VBX...
W. L. Gore & Associates, Inc. (Gore) announced that it is initiating the EMBRACE Registry to capture real-world data about the GORE® VIABAHN® VBX...
W. L. Gore & Associates, Inc. (Gore) a annoncé le lancement du registre EMBRACE afin de recueillir des données réelles sur l'Endoprothèse expansible...
W. L. Gore & Associates, Inc. (Gore) ha anunciado el inicio del Registro EMBRACE para recopilar datos reales sobre la Endoprótesis con balón...
W. L. Gore & Associates (Gore) today announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently...
W. L. Gore & Associates, Inc. (Gore) gab den Abschluss der angestrebten Registrierung für das Post-Market-Register EXPAND für die GORE® VIABAHN® VBX...
W. L. Gore & Associates, Inc. (Gore) ha anunciado la finalización de la inscripción en el registro postcomercialización EXPAND de la Endoprótesis con ...
W. L. Gore & Associates, Inc. (Gore) announced the completion of target enrollment in the EXPAND Post-Market Registry of the GORE® VIABAHN® VBX...
W. L. Gore & Associates, Inc. (Gore) a annoncé l'achèvement du recrutement cible dans le registre post-commercialisation EXPAND de l'Endoprothèse...
W. L. Gore & Associates (Gore) gab heute bekannt, dass der GORE® CARDIOFORM Septal Occluder seit 10 Jahren klinisch eingesetzt wird und Patienten in...
W. L. Gore & Associates (Gore) ha annunciato oggi che l'occlusore settale CARDIOFORM GORE® ha raggiunto i 10 anni di utilizzo clinico, trattando i...
W. L. Gore & Associates (Gore) ha anunciado hoy que el oclusor septal GORE® CARDIOFORM ha cumplido 10 años de uso clínico, tratando a pacientes a...
W. L. Gore & Associates (Gore) a annoncé aujourd'hui que le dispositif d'obturation septale CARDIOFORM de GORE® a atteint 10 ans d'utilisation...
W. L. Gore & Associates (Gore) today announced that the GORE® CARDIOFORM Septal Occluder has achieved 10 years of clinical use, treating patients...
Im Rahmen seiner Bemühungen, die medizinischen Lösungen für Patienten mit komplexen Gefäßerkrankungen kontinuierlich zu verbessern, hat W. L. Gore &...
Como parte de los esfuerzos por mejorar continuamente las soluciones médicas para los pacientes con enfermedades vasculares complejas, W. L. Gore &...
Dans le cadre de ses efforts pour améliorer continuellement les solutions médicales pour les patients souffrant de maladies vasculaires complexes, W. ...
As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore)...
W. L. Gore & Associates (Gore), today announced that five-year results of the U.S. prospective, multicenter study (N = 63) of endovascular repair of...
A multi-year fuel cell supply agreement was announced today between Ballard Power Systems and W. L. Gore & Associates. A signing ceremony at the 6th...
W. L. Gore & Associates is pleased to announce that its GORE-SELECT® Membrane received Toyota Motor Corporation's prestigious Project Award in the...
W. L. Gore & Associates, Inc. (Gore), a global leader in providing solutions for cardiovascular disease, today announced encouraging clinical results ...
Robert W. "Bob" Gore, chairman emeritus of the board of directors of W. L. Gore & Associates, a global material science company dedicated to...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.